Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sauerbrei

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancerT Ahlert, W Sauerbrei, G Bastert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 1993
Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG)M H Seegenschmiedt, W Sauerbrei, R Sauer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrenceK-J Winzer, R Sauer, W Sauerbrei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association StudyW Jonat, M Kaufmann, W Sauerbrei, et al.
British Journal of Cancer|June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMFM Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancerT Ahlert, W Sauerbrei, G Bastert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 1993
Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG)M H Seegenschmiedt, W Sauerbrei, R Sauer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrenceK-J Winzer, R Sauer, W Sauerbrei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association StudyW Jonat, M Kaufmann, W Sauerbrei, et al.
British Journal of Cancer|June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMFM Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Pageof 8